Global Corneal Implants Market is expected to foster appreciable growth opportunities and garner a decent valuation by 2030, owing to the increasing technological advancements in corneal implants. Vision impairment and corneal blindness have become fairly prominent in recent years. The latest estimates by the World Health Organization (WHO) reveal that almost 2.2 billion people globally have a distance or near vision impairment.

The widely expanding patient pool has encouraged industry participants and researchers to undertake R&D projects focusing on developing advanced tools and technologies. The integration of cutting-edge technologies in corneal implants lets eye surgeons be more precise in their treatments, reduces recovery times, decreases the risk of complications, and improves surgery outcomes. For instance, the advent of a femtosecond laser helped overcome suture-associated issues and attain a high grade of customization in corneal transplants.

The corneal implant market is categorized based on tissue, transplant, condition, end-user, and region.

With respect to tissue, the artificial cornea segment is predicted to showcase a remarkable growth rate from 2022 to 2030. The surging incidences of end-stage corneal diseases, such as inflammatory ocular surface disease and multiple graft failures, will boost the adoption of artificial corneal implants over the next eight years. Besides, the limited cornea donations with respect to the number of patients seeking transplantation treatment will augment the market size.

In terms of transplants, the others segment size was valued at over USD 35 billion in 2021 and may witness lucrative growth through 2030. The segment comprises corneal transplantation procedures, including Descemet stripping automated endothelial keratoplasty (DSAEK) and deep anterior lamellar keratoplasty (DALK). DALK procedures cause minimal steroid-related complications and ensure easy follow-ups and better long-term graft revival, increasing their adoption in the forthcoming years.

With regard to condition, the other segment amassed more than 7% market share in 2021 and is poised to record a decent valuation by 2030. The rising incidences of several eye defects caused due to traumatic injury, penetrating injury, keratitis, and bullous keratopathy will drive segment revenues over the next eight years. In addition, the increasing number of patients undergoing corneal transplantation surgeries will create favorable growth scenarios for the corneal implants industry.

Ambulatory Surgical Centers are likely to become a major end-user in the forthcoming years, owing to the increasing customer inclination toward ASCs as a preferred treatment location for eye surgeries. ASCs are equipped with advanced eye care surgeons and advanced tools and equipment, boosting their growth through 2030. These establishments offer same-day surgical care and better outpatient experience, providing them a competitive edge over clinics and hospitals.

The Latin America corneal implant market is projected to observe more than 6.5% growth rate from 2022 to 2030. The regional business is fueled by the massive growth in the geriatric population and the increasing number of people undergoing eye care treatments. In addition, improved access to medical facilities, the availability of all types of corneal inlays, and higher demand from ophthalmologists are a few promising aspects that may contribute towards regional market expansion.